Integer Holdings (ITGR) Cash from Investing Activities (2010 - 2026)
Integer Holdings' (ITGR) quarterly Cash from Investing Activities came in at -$22.7 million in Q3 2026, down 27.25% year-over-year from -$31.2 million in Q3 2025, and up 40.15% quarter-over-quarter from -$37.9 million in Q2 2026.
Analysis
Integer Holdings (ITGR) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Integer Holdings has disclosed Cash from Investing Activities across 17 years of filings, most recently posting -$22.7 million for Q3 2026.
- In Q3 2026, Cash from Investing Activities fell 27.25% year-over-year to -$22.7 million; the TTM figure through Jul 2026 stood at -$116.3 million (up 45.03% YoY), while the FY2025 annual figure was -$270.7 million, down 38.54% from the prior year.
- Cash from Investing Activities came in at -$22.7 million for Q3 2026 at Integer Holdings, up from -$37.9 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $29.6 million in Q4 2024 to a low of -$197.2 million in Q1 2025.
- Average Cash from Investing Activities over 5 years is -$49.5 million, with a median of -$28.4 million recorded in 2024.
- Year-over-year, Cash from Investing Activities plunged 1185.43% in 2022 and soared 136.75% in 2024.
- Over 5 years, Cash from Investing Activities stood at -$31.3 million in 2022, then slumped by 157.26% to -$80.6 million in 2023, then surged by 136.75% to $29.6 million in 2024, then slumped by 219.76% to -$35.5 million in 2025, then surged by 36.04% to -$22.7 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$22.7 million in Q3 2026, -$37.9 million in Q2 2026, and -$35.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Integer Holdings | 4.29 Bn | 4.27 Bn | 112.94 Mn | -22.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | -22.69 Mn |
| Apr 3, 2026 | -37.90 Mn |
| Dec 31, 2025 | -35.47 Mn |
| Sep 26, 2025 | -20.27 Mn |
| Jun 27, 2025 | -17.83 Mn |
| Mar 28, 2025 | -197.17 Mn |
| Dec 31, 2024 | 29.62 Mn |
| Sep 27, 2024 | -26.24 Mn |
| Jun 28, 2024 | -30.60 Mn |
| Mar 29, 2024 | -168.20 Mn |
| Dec 31, 2023 | -80.58 Mn |
| Sep 29, 2023 | -25.42 Mn |
| Jun 30, 2023 | -32.67 Mn |
| Mar 31, 2023 | -24.69 Mn |
| Dec 31, 2022 | -31.32 Mn |
| Sep 30, 2022 | -20.44 Mn |
| Jul 1, 2022 | -138.26 Mn |
| Apr 1, 2022 | -10.40 Mn |
| Dec 31, 2021 | -241.37 Mn |
| Oct 1, 2021 | -11.23 Mn |